TherapeuticsMD, Inc. (TXMD) Net income 2016–2025
TherapeuticsMD, Inc. (TXMD) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$569,000FY2025 · since FY2016: -$89.9M → -$569,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$569,000 | +73.9% |
| FY2024 | -$2.2M | +78.8% |
| FY2023 | -$10.3M | -109.2% |
| FY2022 | $112.0M | +165.0% |
| FY2021 | -$172.4M | +6.1% |
| FY2020 | -$183.5M | -4.2% |
| FY2019 | -$176.1M | -32.8% |
| FY2018 | -$132.6M | -72.4% |
| FY2017 | -$76.9M | +14.4% |
| FY2016 | -$89.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TXMD financial trends
TXMD RevenueTXMD Net marginTXMD Gross profitTXMD Gross marginTXMD Operating incomeTXMD Operating marginTXMD Operating cash flowTXMD Free cash flowTXMD Capital expendituresTXMD Return on equityTXMD Stock buybacksTXMD Dividends paidTXMD Total assetsTXMD Total liabilitiesTXMD Shareholders’ equityTXMD overview →